Pereira et al. speculated that MEX3A participated in the regulation of CDX2 and confirmed that MEX3A inhibited the expression of CDX2 and damaged the differentiation of intestinal cells, suggesting that MEX3A may be an oncogene for colorectal cancer [23]. Here, MEX3A is linked to colorectal cancer.